abstract |
Methods and products for the treatment or prevention of pain and the reduction of nociception are described, comprising the modulation of neuroglia-derived brain-derived neurotrophic factor (BDNF) expression or activity in a mammalian host by the administration of an agent such as the P2X receptor inhibitor, TNP-ATP, a BDNF antisense molecule or BDNF siRNA. Related methods for identifying or characterizing compounds for the treatment or prevention of pain and the reduction of nociception are also described. |